Diplomat Announces 3rd Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
- After-Hours Movers: WDC, BE, DECK, FIX, RNG
Diplomat Pharmacy (DPLO) Tops Q3 EPS by 10c; Lifts FY15 Outlook
November 3, 2015 4:20 PM ESTDiplomat Pharmacy (NYSE: DPLO) reported Q3 EPS of $0.26, $0.10 better than the analyst estimate of $0.16. Revenue for the quarter came in at $947 million versus the consensus estimate of $926.41 million.
Diplomat Pharmacy sees FY2015 EPS of $0.69-$0.73, versus prior guidance of $0.56-$0.60 and the consensus of... More



